Skip to main content

Ocular Therapeutix: Q1 Earnings Snapshot

BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Ocular Therapeutix Inc. (OCUL) on Tuesday reported a loss of $88.6 million in its first quarter.

The Bedford, Massachusetts-based company said it had a loss of 40 cents per share. Losses, adjusted for non-recurring gains, were 41 cents per share.

The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 32 cents per share.

The biotechnology company posted revenue of $10.8 million in the period, which also missed Street forecasts. Four analysts surveyed by Zacks expected $12.7 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCUL at https://www.zacks.com/ap/OCUL

One Tech Tip: What to know about flying with lithium ion portable battery chargers

Jetting off soon for summer travels? If you're planning on bringing an extra battery charger for your phone or other devices, be aware of the latest rules when taking one on a flight. Rechargeable lithium-ion portable battery chargers, also known as power banks, come in protective enclosures of various shapes and sizes. They're a handy and popular way for getting more juice when you're on the move. But after a spate of smoke or fire incidents, U.S. and international aviation authorities have issued new guidelines and airlines have tightened up rules for passengers. Here's a guide on flying with power banks.
Read Next Story

Related News

Knicks take 1-0 lead into game 2 against the Spurs

Beijing bans 4 New Zealand lawmakers from entering China because they visited Taiwan

Police warn families of Tiananmen crackdown dead not to visit graves on 37th anniversary